Jove
Visualize
Contáctanos
JoVE
x logofacebook logolinkedin logoyoutube logo
ACERCA DE JoVE
Visión GeneralLiderazgoBlogCentro de Ayuda JoVE
AUTORES
Proceso de PublicaciónConsejo EditorialAlcance y PolíticasRevisión por ParesPreguntas FrecuentesEnviar
BIBLIOTECARIOS
TestimoniosSuscripcionesAccesoRecursosConsejo Asesor de BibliotecasPreguntas Frecuentes
INVESTIGACIÓN
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchivo
EDUCACIÓN
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualCentro de Recursos para ProfesoresSitio de Profesores
Términos y Condiciones de Uso
Política de Privacidad
Políticas

Videos de Conceptos Relacionados

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.1K
Abnormal Proliferation02:23

Abnormal Proliferation

5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

10.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.4K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

3.9K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.9K
Tumor Progression02:07

Tumor Progression

7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K

También podría leer

Artículos Relacionados

Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.

Ordenar por
Same author

Molecular changes during AT/RT progression associated with epithelial-mesenchymal transition and extracellular matrix changes.

Acta neuropathologica·2026
Same author

Needle-track metastasis in diffuse intrinsic pontine glioma: Need for a standardized surgical strategy?

Neuro-oncology advances·2026
Same author

Deep Learning Predicts Mutations and Outcomes in Gastrointestinal Stromal Tumors from Whole-Slide Images.

Cancer research·2026
Same author

Treatment effect heterogeneity of radiotherapy in localized Ewing sarcoma: A secondary analysis of the EURO-E.W.I.N.G. 99 and Ewing 2008 trial.

European journal of cancer (Oxford, England : 1990)·2026
Same author

Prognostic Value of Regnase-1 in High-Grade Soft Tissue Sarcoma: Favourable in UPS, Yet Inverted in Adjuvantly Irradiated Patients.

Cancers·2026
Same author

VGLL3-Rearranged Spindle Cell Rhabdomyoblastic Tumor: A Clinicopathologic and Molecular Genetic Study of 18 Cases With Consistently Indolent Behavior.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·2026

Video Experimental Relacionado

Updated: Jan 7, 2026

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

4.2K

SS18::SSX y BRD9 modulan la diferenciación del sarcoma sinovial

Anna Kuntze1, Victor Banerjee2, Marcel Trautmann1

  • 1Gerhard-Domagk-Institute of Pathology, University Hospital Münster, 48149 Münster, Germany.

Cells
|December 24, 2025
PubMed
Resumen

El sarcoma sinovial (SySa) está impulsado por SS18::SSX, que afecta a los complejos BAF y la diferenciación celular. Este estudio revela que SS18::SSX y BRD9 regulan los factores de transición epitelio-mesénquima (EMT), influyendo en el fenotipo del tumor SySa.

Palabras clave:
Complejo BAFBRD9E-CadherinaEMTGBAFSS18::SSXSlugSnaildiferenciaciónsarcoma sinovial

Más Videos Relacionados

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

9.8K
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.6K

Videos de Experimentos Relacionados

Last Updated: Jan 7, 2026

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

4.2K
Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
11:42

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells

Published on: April 7, 2017

9.8K
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
08:07

Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma

Published on: April 12, 2019

7.6K

Área de la Ciencia:

  • Oncología
  • Biología Molecular
  • Genética

Sus antecedentes:

  • El sarcoma sinovial (SySa) es una malignidad de tejidos blandos impulsada por la proteína de fusión SS18::SSX.
  • Esta proteína de fusión afecta a los complejos de remodelación de la cromatina BAF, alterando la transcripción génica y provocando heterogeneidad tumoral.
  • Los tratamientos actuales tienen una eficacia limitada, lo que requiere una comprensión más profunda de los mecanismos moleculares de SySa.

Objetivo del estudio:

  • Investigar los roles de SS18::SSX y subunidades BAF específicas en la diferenciación de SySa.
  • Explorar cómo estos componentes regulan la transición epitelio-mesénquima (EMT) y los factores asociados.

Principales métodos:

  • Se utilizó el análisis de Nanostring para evaluar los cambios en la expresión génica tras el silenciamiento de SS18::SSX y BRD9.
  • Se analizaron datos publicados de secuenciación de ARN de célula única para validar los hallazgos.
  • Enfoque en SS18::SSX, BRD9, factores de EMT (Snail, Slug) y expresión de E-Cadherina.

Principales resultados:

  • El silenciamiento de SS18::SSX y la subunidad GBAF BRD9 modularon las vías de diferenciación celular de SySa.
  • Tanto SS18::SSX como BRD9 regulan los factores asociados a EMT Snail y Slug.
  • Se identificó SS18::SSX como un represor de la expresión de E-Cadherina, un marcador clave de EMT.

Conclusiones:

  • SS18::SSX y BRD9 desempeñan papeles cruciales en la regulación de los jugadores clave de EMT en SySa.
  • Estas interacciones proporcionan nuevas perspectivas sobre la regulación multicapa del fenotipo tumoral y potencialmente el pronóstico en SySa.
  • La comprensión de estos mecanismos puede guiar el desarrollo de nuevas estrategias terapéuticas para SySa.